A reused roll or a ‘curious Christian codex’? Reconsidering British Library Papyrus 2053 (P.Oxy. 8.1075 + P.Oxy. 8.1079)
Buried History: The Journal of the Australian Institute of Archaeology · 2018
DOI: 10.62614/21ppa442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Buried History: The Journal of the Australian Institute of Archaeology, 2018. Verfasst von Scott D. Charlesworth. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Recently, Brent Nongbri has proposed that British Library Papyrus 2053 came from a codex and not a roll. His primary concern is codicology and he pays no attention to scribal tendencies, including the implications of the palaeographical characteristics of the hand. In a careful reassessment that takes into consideration codicology, palaeography, scribal tendencies, and the physical condition of the papyrus itself, Nongbri’s argument is found to be flawed in a number of ways which speak directly to the possible origins of BL Pap. 2053. All indications are that a third-century Christian used the back of a roll containing Exodus to produce a copy of Revelation for ‘private’ use.
Zitieren
APA
Charlesworth, S. D. (2018). A reused roll or a ‘curious Christian codex’? Reconsidering British Library Papyrus 2053 (P.Oxy. 8.1075 + P.Oxy. 8.1079). Buried History: The Journal of the Australian Institute of Archaeology. https://doi.org/10.62614/21ppa442
Vancouver
Charlesworth SD. A reused roll or a ‘curious Christian codex’? Reconsidering British Library Papyrus 2053 (P.Oxy. 8.1075 + P.Oxy. 8.1079). Buried History: The Journal of the Australian Institute of Archaeology. 2018. doi:10.62614/21ppa442
BibTeX
@article{Charlesworth2018,
author = {Charlesworth, Scott D.},
title = {A reused roll or a ‘curious Christian codex’? Reconsidering British Library Papyrus 2053 (P.Oxy. 8.1075 + P.Oxy. 8.1079)},
journal = {Buried History: The Journal of the Australian Institute of Archaeology},
year = {2018},
doi = {10.62614/21ppa442}
}
EUVIMED